BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $602,000 | +1.7% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $592,000 | +7.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $553,000 | -6.9% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $594,000 | -1.3% | 500,000 | 0.0% | 0.01% | +33.3% |
| Q3 2017 | $602,000 | +0.7% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $598,000 | +0.8% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $593,000 | +0.7% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q4 2016 | $589,000 | -5.6% | 500,000 | 0.0% | 0.01% | +14.3% |
| Q3 2016 | $624,000 | +7.8% | 500,000 | 0.0% | 0.01% | +16.7% |
| Q2 2016 | $579,000 | -2.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $594,000 | -11.6% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $672,000 | +2.9% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $653,000 | -17.6% | 500,000 | 0.0% | 0.01% | +16.7% |
| Q2 2015 | $792,000 | +4.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $758,000 | +24.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $611,000 | +11.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $550,000 | +1.9% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $540,000 | -2.4% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $553,000 | +2.8% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q4 2013 | $538,000 | – | 500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |